Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GREGORY B HAMMER

Allopathic & Osteopathic Physicians Anesthesiology

NPI
1396885455
CMS profile
944088
Location
STANFORD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$7,900.36

5 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Trevena, Inc. $5,024.13 2
Edwards Lifesciences Corporation $2,750.00 2
Acacia Pharma Inc $126.23 1

Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GREGORY B HAMMER

NPI 1396885455 · CMS profile ID 944088

Allopathic & Osteopathic Physicians / Anesthesiology

STANFORD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396885455?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GREGORY B HAMMER, NPI 1396885455, CMS profile ID 944088. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396885455?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). GREGORY B HAMMER, NPI 1396885455, CMS profile ID 944088. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396885455?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
GREGORY B HAMMER, NPI 1396885455, CMS profile ID 944088, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–5 of 5 matching records. This page contains 5 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1396885455?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

5 matching records · $7,900.36 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 5 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–5 of 5.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Trevena, Inc. $24.1310/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855190259 CMS
Edwards Lifesciences Corporation $500.0010/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841826401 CMS
Acacia Pharma Inc $126.2305/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853755077 CMS
Trevena, Inc. $5,000.0003/14/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855192131 CMS
Edwards Lifesciences Corporation $2,250.0003/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841826399 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,777.27 8
PY2020 $2,500.00 2
PY2021 $7,900.36 5
PY2022 $1,125.00 1
PY2023 $1,125.00 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $13,296.00 3
PY2023 Recipient $3,200.00 1
PY2023 Principal investigator $192,152.84 3
PY2022 Recipient $330.00 1
PY2022 Principal investigator $406,381.59 42
PY2021 Recipient $4,000.00 1
PY2021 Principal investigator $395,644.11 30
PY2020 Principal investigator $261,247.84 61
PY2019 Principal investigator $566,446.06 129

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

43 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $2,707.61 12/31/2022 Non-covered Recipient Entity
LUCILLE PACKARD CHILDRENS HOSPITAL
A Phase 4 Double-Blinded, Randomized, Active Comparator-Controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex MK-8616 for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to 2 Years No dispute reported 06/30/2026 940388085
Principal investigator 1 Merck Sharp & Dohme LLC $296.38 12/31/2022 Non-covered Recipient Entity
LUCILLE PACKARD CHILDRENS HOSPITAL
A Phase 4 Double-Blinded, Randomized, Active Comparator-Controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex MK-8616 for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to 2 Years No dispute reported 06/30/2026 940388087
Principal investigator 1 Merck Sharp & Dohme LLC $4,537.35 12/31/2022 Non-covered Recipient Entity
LUCILLE PACKARD CHILDRENS HOSPITAL
A Phase 4 Double-Blinded, Randomized, Active Comparator-Controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex MK-8616 for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to 2 Years No dispute reported 06/30/2026 940388089
Principal investigator 1 ACACIA PHARMA INC $193.28 11/21/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563353
Principal investigator 1 ACACIA PHARMA INC $64,515.17 11/21/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563355
Principal investigator 1 ACACIA PHARMA INC $153.60 11/18/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563339
Principal investigator 1 ACACIA PHARMA INC $734.72 11/18/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563341
Principal investigator 1 ACACIA PHARMA INC $1,952.64 11/18/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563343
Principal investigator 1 ACACIA PHARMA INC $3,751.68 11/18/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563345
Principal investigator 1 ACACIA PHARMA INC $5,857.92 11/18/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563347
Principal investigator 1 ACACIA PHARMA INC $7,810.56 11/18/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563349
Principal investigator 1 ACACIA PHARMA INC $9,028.48 11/18/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563351
Recipient PFIZER INC. $330.00 11/15/2022 Covered Recipient Physician HOSPITAL BRANDS CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 949717265
Principal investigator 1 ACACIA PHARMA INC $4,698.88 10/27/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563329
Principal investigator 1 ACACIA PHARMA INC $8,514.88 10/27/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563331
Principal investigator 1 ACACIA PHARMA INC $9,661.44 10/27/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563333
Principal investigator 1 ACACIA PHARMA INC $9,443.84 10/27/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563335
Principal investigator 1 ACACIA PHARMA INC $4,505.60 10/26/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563323
Principal investigator 1 ACACIA PHARMA INC $8,864.00 10/26/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563325
Principal investigator 1 ACACIA PHARMA INC $9,081.60 10/26/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563327
Principal investigator 1 ACACIA PHARMA INC $25,544.64 10/25/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563317
Principal investigator 1 ACACIA PHARMA INC $25,544.64 10/25/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563319
Principal investigator 1 ACACIA PHARMA INC $17,029.76 10/25/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563321
Principal investigator 1 ACACIA PHARMA INC $6,795.65 09/23/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563305
Principal investigator 1 ACACIA PHARMA INC $37,061.57 09/16/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563289
Principal investigator 1 ACACIA PHARMA INC $734.72 09/16/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563291
Principal investigator 1 ACACIA PHARMA INC $153.60 08/16/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563277
Principal investigator 1 ACACIA PHARMA INC $14,459.04 08/16/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563279
Principal investigator 1 ACACIA PHARMA INC $4,338.70 08/16/2022 Non-covered Recipient Entity
STANFORD UNIVERSITY
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563281
Principal investigator 1 Merck Sharp & Dohme LLC $20,515.12 07/11/2022 Non-covered Recipient Entity
LUCILLE PACKARD CHILDRENS HOSPITAL
A Phase 4 Double-Blinded, Randomized, Active Comparator-Controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex MK-8616 for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to 2 Years No dispute reported 06/30/2026 940388083
Principal investigator 1 ACACIA PHARMA INC $27,182.60 05/24/2022 Non-covered Recipient Entity
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNV
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563271
Principal investigator 1 ACACIA PHARMA INC $24,725.65 05/03/2022 Non-covered Recipient Entity
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNV
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563269
Principal investigator 1 Masimo Corporation $263.18 04/29/2022 Covered Recipient Teaching Hospital
Stanford Health Care
Hammer/Lucile Packard Children's Hospital at Stanford/ Convenience Sample Data Collection for INVSENSOR00045 No dispute reported 06/30/2026 964244691
Principal investigator 1 Masimo Corporation $20.31 04/29/2022 Covered Recipient Teaching Hospital
Stanford Health Care
Hammer/Lucile Packard Children's Hospital at Stanford/ Convenience Sample Data Collection for INVSENSOR00045 No dispute reported 06/30/2026 964244697
Principal investigator 1 Masimo Corporation $9.65 04/29/2022 Covered Recipient Teaching Hospital
Stanford Health Care
Hammer/Lucile Packard Children's Hospital at Stanford/ Convenience Sample Data Collection for INVSENSOR00045 No dispute reported 06/30/2026 964244699
Principal investigator 1 Masimo Corporation $662.97 04/29/2022 Covered Recipient Teaching Hospital
Stanford Health Care
Hammer/Lucile Packard Children's Hospital at Stanford/ Convenience Sample Data Collection for INVSENSOR00045 No dispute reported 06/30/2026 964244705
Principal investigator 1 Masimo Corporation $1,200.00 04/29/2022 Covered Recipient Teaching Hospital
Stanford Health Care
Hammer/Lucile Packard Children's Hospital at Stanford/ Convenience Sample Data Collection for INVSENSOR00045 No dispute reported 06/30/2026 964244711
Principal investigator 1 Masimo Corporation $350.00 04/29/2022 Covered Recipient Teaching Hospital
Stanford Health Care
Hammer/Lucile Packard Children's Hospital at Stanford/ Convenience Sample Data Collection for INVSENSOR00045 No dispute reported 06/30/2026 964244717
Principal investigator 1 Masimo Corporation $13.80 04/29/2022 Covered Recipient Teaching Hospital
Stanford Health Care
Hammer/Lucile Packard Children's Hospital at Stanford/ Convenience Sample Data Collection for INVSENSOR00045 No dispute reported 06/30/2026 964244725
Principal investigator 1 PFIZER INC. $34,379.40 04/08/2022 Non-covered Recipient Entity
Stanford University Lockbox
A PHASE 34 RANDOMIZED DOUBLEBLIND DOSERANGING STUDY OF THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE DEX USED WITH PROPOFOL PRO AS NEEDED FOR PROCEDURAL SEDATION OF PEDIATRIC SUBJECTS 1 MONTH TO 17 YEARS OF AGE UNDERGOING MRI SCANS No dispute reported 06/30/2026 949808623
Principal investigator 1 PFIZER INC. $5,120.00 03/24/2022 Non-covered Recipient Entity
Stanford University Lockbox
A PHASE 34 RANDOMIZED DOUBLEBLIND DOSERANGING STUDY OF THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE DEX USED WITH PROPOFOL PRO AS NEEDED FOR PROCEDURAL SEDATION OF PEDIATRIC SUBJECTS 1 MONTH TO 17 YEARS OF AGE UNDERGOING MRI SCANS No dispute reported 06/30/2026 949808935
Principal investigator 1 ACACIA PHARMA INC $3,470.96 02/23/2022 Non-covered Recipient Entity
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNV
INVESTIGATION OF REMIMAZOLAM IN CHILDREN UNDERGOING SEDATION FOR MEDICAL PROCEDURES No dispute reported 06/30/2026 937563259
Principal investigator 1 PFIZER INC. $496.00 01/07/2022 Non-covered Recipient Entity
Stanford University Lockbox
A PHASE 34 RANDOMIZED DOUBLEBLIND DOSERANGING STUDY OF THE SAFETY AND EFFICACY OF DEXMEDETOMIDINE DEX USED WITH PROPOFOL PRO AS NEEDED FOR PROCEDURAL SEDATION OF PEDIATRIC SUBJECTS 1 MONTH TO 17 YEARS OF AGE UNDERGOING MRI SCANS No dispute reported 06/30/2026 949805955